Disease-a-month : DM
Foreword: Patient-accessible continuous glucose monitoring for cardiometabolic risk reduction in type 2 diabetes: A meta-analysis of randomized controlled trials.
Jerrold B Leikin
Published: 202510.1016/j.disamonth.2025.102042
No abstract available for this study.